# E33 Test Evidence

MED-1343 through MED-1345 add draft-only Play listing, privacy/Data Safety, and release-profile evidence plus automated protected-environment checks. Release configuration rejects protected HTTP/loopback backends and secret-like `EXPO_PUBLIC_*` names. No Play upload, signing credential, signed AAB, legal approval, production deployment, or clinical validation is established.

MED-1334 through MED-1342 add Android 10–15+ configuration/static checks, state-recreation and low-memory resilience coverage, large-text wrapping/control coverage, TalkBack semantic coverage, and an explicit device-evidence matrix. No emulator, system image, AVD, or connected physical device was available on 2026-09-14, so version-specific runtime, memory-pressure, Android system-font-scale, and manual TalkBack execution remain pending. Warning alerts and medication cards received narrowly scoped accessibility-semantic corrections.

MED-1332–1333 add allowlist, malformed/sensitive/action-link, auth/onboarding-gate, notification-route, permission, token rotation/unavailable, offline, backend failure, logout revocation, endpoint-contract, and lock-screen privacy tests. Static checks assert no token logging, AsyncStorage token persistence, direct service clients, clinical payloads, or automatic medication/SOS actions.

MED-1328 through MED-1331 add preference restoration/persistence, design-token propagation, runtime localization, E22 translation-boundary, offline TTL/stale/corruption/bounds, fail-safe offline action, and SecureStore availability/corruption tests. Final command results are recorded in the branch handoff and do not establish production or clinical validation.

MED-1325 through MED-1327 add cross-feature tests for self-reported symptom input, pending validated assessment, SOS confirmation/cancellation, deterministic navigation intents, blocked clinical voice commands, and absence of logging, persistence, location, SMS, or fabricated clinical routes.

MED-1322 through MED-1324 add tests for all display states, textual severity, prescription confirmation/correction/rejection, explicit processing, transient-image privacy, inventory validation, incomplete-estimate behavior, pending adapters, and prohibited clinical advice.

MED-1318 through MED-1321 add component, action-state, backend-contract, evidence-status, translation, history, failure-sanitization, navigation, privacy, and clinical-language coverage. Final command results are reported at feature-branch handoff and do not establish clinical validation or production readiness.

Scope: MED-1304 through MED-1310 mobile foundation. Automated tests cover environment rejection, protected route decisions, logout routing, component accessibility/loading/error states, Indian phone and OTP bounds, backend auth payloads, secure token persistence, sanitized auth errors, onboarding progression, and safety language.

Required final commands are `npm run typecheck`, `npm run lint`, `npm test -- --runInBand`, and `npx expo config --type public`. Static scans verify no credential patterns, token logging, or auth-token AsyncStorage use. Device deployment, production readiness, and clinical validation are outside this batch.

The initial npm audit reports 14 moderate transitive advisories in Expo Router/Expo build tooling. npm's proposed forced fix downgrades SDK-critical packages and was not applied. These advisories require upstream-compatible Expo updates and remain a release-governance follow-up; no high or critical advisory was reported.

MED-1311–1317 coverage adds patient/caregiver dashboard states, quick actions, authorized context selection, medicine lists and refresh, manual-entry bounds and submission locking, camera permission/capture/retake/explicit continuation, OCR editing/rejection/retry/manual fallback/mandatory confirmation, schedule date and time constraints, real backend route assertions, and pending-adapter assertions. Static checks cover direct cloud/database clients, secrets, token logging, AsyncStorage token use, and captured-image logging/persistence.
